Diltiazem: Difference between revisions
ClaireLewis (talk | contribs) |
ClaireLewis (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
==Administration== | |||
*Type: [[Calcium channel blocker]] | |||
*Dosage Forms: | |||
*Routes of Administration: IV, PO | |||
*Common Trade Names: Cardizem | |||
==Indications== | |||
*Conversion of PSVT to NSR | |||
*Slow RVR in a-fib/flutter | |||
==Adult Dosing== | ==Adult Dosing== | ||
*Loading dose = 0.25mg/kg (max=20mg) IV bolus over 2min | *Loading dose = 0.25mg/kg (max=20mg) IV bolus over 2min | ||
Line 9: | Line 20: | ||
==Special Populations== | ==Special Populations== | ||
* Pregnancy Rating: | * Pregnancy Rating: C | ||
* Lactation: | * Lactation: | ||
* Renal Dosing | * Renal Dosing: Not studied, use caution | ||
* Hepatic Dosing: Not studied, use caution | |||
* Hepatic Dosing | |||
==Contraindications== | ==Contraindications== | ||
*Wide-complex tachycardia due to bypass tract | *Allergy to drug/class | ||
*Infants <1yo | |||
*Wide-complex tachycardia due to bypass tract (e.g. WPW) | |||
*Symptomatic severe hypotension | |||
*Sick sinus syndrome/2nd or 3rd degree heart block if no pacemaker | |||
*PO: acute MI and pulmonary congestion | |||
*Ventricular tachycardia | |||
*Caution if: | |||
**Hypertrophic cardiomyopathy | |||
**LV dysfunction | |||
**Concomitant beta-blockade | |||
**Hepatic/renal impairment | |||
**Heart failure | |||
==Adverse Reactions== | |||
===Serious=== | |||
*Bradycardia, AV block, BBB | |||
*Hypotension | |||
*CHF | |||
*SJS/TEN | |||
===Common=== | |||
*Peripheral edema | |||
*Elevated LFTs | |||
*Headache | |||
*Dizziness | |||
*Nausea/vomiting, diarrhea, contipation | |||
*Flushing, vasodilation | |||
*Gingival hyperplagia | |||
*Myalgia | |||
*Bronchitis, sinus congestion, dypsnea | |||
*Hemolytic anemia, thrombocytopenia | |||
*Extrapyramidal symptoms | |||
== | ==Pharmacology | ||
* | *Onset of action = 2-3min (IV) | ||
* | *Duration of action = 1-3hr (IV) | ||
*Half life: 3-5h | |||
*Metabolism: Hepatic | |||
*Excretion: Urine/feces | |||
==Mechanism of Action== | ==Mechanism of Action== | ||
*Class IV - Inhibits Ca influx | *Class IV - Inhibits Ca influx | ||
**Slows AV nodal conduction | **Slows AV nodal conduction | ||
==See Also== | ==See Also== | ||
Line 42: | Line 77: | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Cardiology]] |
Revision as of 00:29, 21 September 2019
Administration
- Type: Calcium channel blocker
- Dosage Forms:
- Routes of Administration: IV, PO
- Common Trade Names: Cardizem
Indications
- Conversion of PSVT to NSR
- Slow RVR in a-fib/flutter
Adult Dosing
- Loading dose = 0.25mg/kg (max=20mg) IV bolus over 2min
- If ineffective after 15min: 0.35mg/kg (max=25mg) over 2min
- If effective: Start infusion at 5-15mg/hr
Pediatric Dosing
- Contraindicated in pediatric patients <1yo
- See critical care quick reference for drug doses by weight
Special Populations
- Pregnancy Rating: C
- Lactation:
- Renal Dosing: Not studied, use caution
- Hepatic Dosing: Not studied, use caution
Contraindications
- Allergy to drug/class
- Infants <1yo
- Wide-complex tachycardia due to bypass tract (e.g. WPW)
- Symptomatic severe hypotension
- Sick sinus syndrome/2nd or 3rd degree heart block if no pacemaker
- PO: acute MI and pulmonary congestion
- Ventricular tachycardia
- Caution if:
- Hypertrophic cardiomyopathy
- LV dysfunction
- Concomitant beta-blockade
- Hepatic/renal impairment
- Heart failure
Adverse Reactions
Serious
- Bradycardia, AV block, BBB
- Hypotension
- CHF
- SJS/TEN
Common
- Peripheral edema
- Elevated LFTs
- Headache
- Dizziness
- Nausea/vomiting, diarrhea, contipation
- Flushing, vasodilation
- Gingival hyperplagia
- Myalgia
- Bronchitis, sinus congestion, dypsnea
- Hemolytic anemia, thrombocytopenia
- Extrapyramidal symptoms
==Pharmacology
- Onset of action = 2-3min (IV)
- Duration of action = 1-3hr (IV)
- Half life: 3-5h
- Metabolism: Hepatic
- Excretion: Urine/feces
Mechanism of Action
- Class IV - Inhibits Ca influx
- Slows AV nodal conduction